Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07386496
NA

The Role of 18F-PSMA PET in Prostate Cancer Diagnosis in Equivocal MRI

Sponsor: Chinese University of Hong Kong

View on ClinicalTrials.gov

Summary

This study is a multi-center RCT to compare the clinically significant prostate cancer (csPCa) detection and/or change in clinical management in MRI guided (MRI arm) biopsy and MRI+18F-PSMA guided (Combined arm) biopsies in men with equivocal MRI prostate scans. If additional clinical value is shown by adding 18F-PSMA PET to equivocal MRI, then this should be the new standard of care.

Official title: The Role of 18F-PSMA PET in Prostate Cancer Diagnosis in Equivocal MRI: a Multi-center Randomised Controlled Trial

Key Details

Gender

MALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

250

Start Date

2026-03-01

Completion Date

2028-03-31

Last Updated

2026-02-04

Healthy Volunteers

No

Conditions

Interventions

PROCEDURE

MRI+PSMA-guided approach

MRI+PSMA-guided approach prostate biopsy

PROCEDURE

MRI-guided approach

MRI-guided approach prostate biopsy

Locations (1)

Prince of Wales Hospital

Hong Kong, Hong Kong